End of the oldest controversy in medicine. Are we ready to conclude the debate on digitalis?
暂无分享,去创建一个
[1] M. Gheorghiade,et al. WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .
[2] B. Uretsky,et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. , 1993, Journal of the American College of Cardiology.
[3] E. Prystowsky,et al. Physiological Substrate for Antidromic Reciprocating Tachycardia: Prerequisite Characteristics of the Accessory Pathway and Atrioventricular Conduction System , 1992, Circulation.
[4] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.
[5] R. Schlant,et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. , 1989, The New England journal of medicine.
[6] G. Guyatt,et al. A controlled trial of digoxin in congestive heart failure. , 1988, The American journal of cardiology.
[7] A. Jaffe,et al. Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. , 1986, The New England journal of medicine.
[8] K. Bailey,et al. Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methods. , 1986, Circulation.
[9] J. Fleiss,et al. Effect of digitalis treatment on survival after acute myocardial infarction. , 1985, The American journal of cardiology.
[10] R. A. Johnson,et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.
[11] A. Moss,et al. Digitalis‐associated Cardiac Mortality After Myocardial Infarction , 1981, Circulation.